Lonafarnib

Lonafarnib
Trade Name
Orphan Indication Hepatitis D
USA Market Approval USA
USA Designation Date 2013-11-19 00:00:00
Sponsor Eiger Biopharmaceuticals, Inc.;PO Box 430;San Carlos, California, 94070